Condition
Neuroblastoma, Recurrent, Refractory clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neuroblastoma, Recurrent, Refractory clinical trials that are recruiting, at sites in 2 countries (most in Iran (1), China (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Using engineered T-cells to treat relapsed or refractory neuroblastoma in children
This study is testing a new type of engineered T-cell treatment for children with relapsed or hard-to-treat neuroblastoma to see if it can help fight their cancer.
-
Using NK cells to treat high-risk neuroblastoma in children
This study is testing if injections of special immune cells can help children aged 2 to 16 with tough-to-treat neuroblastoma feel better and improve their chances of recovery.
Related topics
Quick answers
How many Neuroblastoma, Recurrent, Refractory clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Iran (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.